Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AM Rx vs RxION Health

AM Rx
Graded #490

Lower grade

vs+6.5
RxION Health
Graded #414

Higher grade

The verdict

RxION Health takes it — 56.4/100 to 49.9/100.

RxION Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxION Health offers compounded semaglutide and tirzepatide including microdosing.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAM Rx +6
51
45
Dose & formulationAM Rx +25
65
40
Clinical oversightRxION Health +41
41
82
Labs & monitoringRxION Health +3
49
52
FulfillmentRxION Health +13
58
71
Contract termsRxION Health +35
20
55
AM Rx · left barRxION Health · right bar

The numbers

MetricAM RxRxION Health
WeighScore49.9/10056.4/100
GradeCC
Scorecard rank#490#414
Semaglutide$151/mo (quarterly plan, plus a separate fee, compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
AM Rx

Graded #490 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available with providers averaging 10+ years' experience
  • Compounded semaglutide from $151/mo on the quarterly plan

Where it loses points

  • Active FTC/DOJ lawsuit over deceptive billing and subscription practices
  • Novo Nordisk false-advertising lawsuit (Aug 2025)
  • Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
RxION Health

Graded #414 · C

Strengths

  • LegitScript Certified
  • Offers both semaglutide and tirzepatide, including microdosing
  • HIPAA compliant
  • States its medications are FDA-regulated

Where it loses points

  • No physical address listed
  • No named pharmacy partners
  • Not available to residents of New Jersey, Alaska, or Mississippi

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard